Keep Me Logged In
Kokou Agbo-Bloua, head of equity and derivative strategy for Europe at BNP Paribas, says that Pfizer is likely to submit another bid to acquire AstraZeneca as a deal would still make "a lot of sense".
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by